Chronic Chlamydia pneumoniae infection and asthma exacerbations in children

This study was undertaken to investigate the reported association between Chlamydia pneumoniae and Mycoplasma pneumoniae infection and the expression of asthma-related symptoms. One hundred and eight children with asthma symptoms, aged 9-11 yrs, completed a 13 month longitudinal study. The children maintained a daily diary of respiratory symptoms and peak flow rates. When respiratory symptoms were reported an investigator was called and a nasal aspirate obtained. In total 292 episodes were reported. After the study 65 children provided samples when asymptomatic. The presence of infection was investigated by the polymerase chain reaction for C. pneumoniae and M. pneumoniae and C. pneumoniae secretory immunoglobulin A (IgA) was detected by amplified enzyme immunoassay. C. pneumoniae detections were similar between the symptomatic and asymptomatic episodes (23 versus 28%, respectively). Children who reported multiple episodes also tended to remain PCR positive for C. pneumoniae suggesting chronic infection (p< 0.02). C. pneumoniae-specific secretory-IgA antibodies were more than seven times greater in subjects who reported four or more exacerbations in the study compared to those who reported just one (p<0.02). M. pneumoniae was found in two of 292 reports and in two of 65 asymptomatic samples. In conclusion, chronic Chlamydia pneumoniae infection is common in schoolage children and immune responses to C. pneumoniae are positively associated with frequency of asthma exacerbations. We suggest that the immune response to chronic C. pneumoniae infection may interact with allergic inflammation to increase asthma symptoms. In contrast Mycoplasma pneumoniae was not found to be important in this study.

This article has been cited by other articles:

				W. C. Webley, Y. Tilahun, K. Lay, K. Patel, E. S. Stuart, C. Andrzejewski, and P. S. Salva Occurrence of Chlamydia trachomatis and Chlamydia pneumoniae in paediatric respiratory infections Eur. Respir. J., February 1, 2009; 33(2): 360 - 367. [Abstract] [Full Text] [PDF]

				A. Sykes, T. Seemungal, and ICEAD contributors Recent advances in exacerbations of asthma Thorax, September 1, 2008; 63(9): 758 - 760. [Full Text] [PDF]

				B G G Oliver, S Lim, P Wark, V Laza-Stanca, N King, J L Black, J K Burgess, M Roth, and S L Johnston Rhinovirus exposure impairs immune responses to bacterial products in human alveolar macrophages Thorax, June 1, 2008; 63(6): 519 - 525. [Abstract] [Full Text] [PDF]

				G. E. Kaiko, S. Phipps, D. K. Hickey, C. E. Lam, P. M. Hansbro, P. S. Foster, and K. W. Beagley Chlamydia muridarum Infection Subverts Dendritic Cell Function to Promote Th2 Immunity and Airways Hyperreactivity J. Immunol., February 15, 2008; 180(4): 2225 - 2232. [Abstract] [Full Text] [PDF]

				J. C. Horvat, K. W. Beagley, M. A. Wade, J. A. Preston, N. G. Hansbro, D. K. Hickey, G. E. Kaiko, P. G. Gibson, P. S. Foster, and P. M. Hansbro Neonatal Chlamydial Infection Induces Mixed T-Cell Responses That Drive Allergic Airway Disease Am. J. Respir. Crit. Care Med., September 15, 2007; 176(6): 556 - 564. [Abstract] [Full Text] [PDF]

				N. Rodriguez, J. Mages, H. Dietrich, N. Wantia, H. Wagner, R. Lang, and T. Miethke MyD88-dependent changes in the pulmonary transcriptome after infection with Chlamydia pneumoniae Physiol Genomics, July 18, 2007; 30(2): 134 - 145. [Abstract] [Full Text] [PDF]

				A M Singh and W W Busse Asthma exacerbations {middle dot} 2: Aetiology Thorax, September 1, 2006; 61(9): 809 - 816. [Abstract] [Full Text] [PDF]

				A. L. Kozyrskyj, M. E. Dahl, W. J. Ungar, A. B. Becker, and B. J. Law Antibiotic treatment of wheezing in children with asthma: what is the practice? Pediatrics, June 1, 2006; 117(6): e1104 - e1110. [Abstract] [Full Text] [PDF]

				D D Creer, J P Dilworth, S H Gillespie, A R Johnston, S L Johnston, C Ling, S Patel, G Sanderson, P G Wallace, and T D McHugh Aetiological role of viral and bacterial infections in acute adult lower respiratory tract infection (LRTI) in primary care Thorax, January 1, 2006; 61(1): 75 - 79. [Abstract] [Full Text] [PDF]

				S. L. Johnston and R. J. Martin Chlamydophila pneumoniae and Mycoplasma pneumoniae: A Role in Asthma Pathogenesis? Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1078 - 1089. [Abstract] [Full Text] [PDF]

				N Teig, A Anders, C Schmidt, C Rieger, and S Gatermann Chlamydophilapneumoniae and Mycoplasma pneumoniae in respiratory specimens of children with chronic lung diseases Thorax, November 1, 2005; 60(11): 962 - 966. [Abstract] [Full Text] [PDF]

				G.L. Biscione, J. Corne, A.J. Chauhan, and S.L. Johnston Increased frequency of detection of Chlamydophila pneumoniae in asthma Eur. Respir. J., November 1, 2004; 24(5): 745 - 749. [Abstract] [Full Text] [PDF]

				C Contini, R Cultrera, S Seraceni, M Castellazzi, E Granieri, and E Fainardi Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis Multiple Sclerosis, August 1, 2004; 10(4): 360 - 369. [Abstract] [PDF]

				A. L. Kozyrskyj, A. G. Carrie, G. B. Mazowita, L. M. Lix, T. P. Klassen, and B. J. Law Decrease in antibiotic use among children in the 1990s: not all antibiotics, not all children Can. Med. Assoc. J., July 20, 2004; 171(2): 133 - 138. [Abstract] [Full Text] [PDF]

				F. Blasi Atypical pathogens and respiratory tract infections Eur. Respir. J., July 1, 2004; 24(1): 171 - 182. [Abstract] [Full Text] [PDF]

				L. D. Snyder and M. D. Eisner Obstructive Lung Disease Among the Urban Homeless Chest, May 1, 2004; 125(5): 1719 - 1725. [Abstract] [Full Text] [PDF]

				F. Blasi, S. Centanni, and L. Allegra Chlamydia pneumoniae: crossing the barriers? Eur. Respir. J., April 1, 2004; 23(4): 499 - 500. [Full Text] [PDF]

				R. A. Pauwels Similarities and Differences in Asthma and Chronic Obstructive Pulmonary Disease Exacerbations Proceedings of the ATS, April 1, 2004; 1(2): 73 - 76. [Abstract] [Full Text] [PDF]

				The ENFUMOSA Study Group The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma Eur. Respir. J., September 1, 2003; 22(3): 470 - 477. [Abstract] [Full Text] [PDF]

				T A R Seemungal, J A Wedzicha, P K MacCallum, S L Johnston, P A Lambert, F Blasi, L Allegra, S Damato, R Raccanelli, R Cosentini, et al. Chlamydia pneumoniae and COPD exacerbation Thorax, December 1, 2002; 57(12): 1087 - 1089. [Full Text] [PDF]

				P.A.B. Wark, S.L. Johnston, J.L. Simpson, M.J. Hensley, and P.G. Gibson Chlamydia pneumoniae immunoglobulin A reactivation and airway inflammation in acute asthma Eur. Respir. J., October 1, 2002; 20(4): 834 - 840. [Abstract] [Full Text] [PDF]

				M. Kraft, G. H. Cassell, J. Pak, and R. J. Martin Mycoplasma pneumoniae and Chlamydia pneumoniae in Asthma* : Effect of Clarithromycin Chest, June 1, 2002; 121(6): 1782 - 1788. [Abstract] [Full Text] [PDF]

				N. G. Papadopoulos, M. Moustaki, M. Tsolia, A. Bossios, E. Astra, A. Prezerakou, D. Gourgiotis, and D. Kafetzis Association of Rhinovirus Infection with Increased Disease Severity in Acute Bronchiolitis Am. J. Respir. Crit. Care Med., May 1, 2002; 165(9): 1285 - 1289. [Abstract] [Full Text] [PDF]

				L.C. von Hertzen Role of persistent infection in the control and severity of asthma: focus on Chlamydia pneumoniae Eur. Respir. J., March 1, 2002; 19(3): 546 - 556. [Abstract] [Full Text] [PDF]

				T. SEEMUNGAL, R. HARPER-OWEN, A. BHOWMIK, I. MORIC, G. SANDERSON, S. MESSAGE, P. MACCALLUM, T. W. MEADE, D. J. JEFFRIES, S. L. JOHNSTON, et al. Respiratory Viruses, Symptoms, and Inflammatory Markers in Acute Exacerbations and Stable Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1618 - 1623. [Abstract] [Full Text] [PDF]

				S. L. Johnston Is Chlamydia pneumoniae Important in Asthma? . The First Controlled Trial of Therapy Leaves the Question Unanswered Am. J. Respir. Crit. Care Med., August 15, 2001; 164(4): 513 - 514. [Full Text] [PDF]

				P. N. BLACK, F. BLASI, C. R. JENKINS, R. SCICCHITANO, G. D. MILLS, A. R. RUBINFELD, R. E. RUFFIN, P. R. MULLINS, J. DANGAIN, B. C. COOPER, et al. Trial of Roxithromycin in Subjects with Asthma and Serological Evidence of Infection with Chlamydia pneumoniae Am. J. Respir. Crit. Care Med., August 15, 2001; 164(4): 536 - 541. [Abstract] [Full Text] [PDF]

				J. M. CORNE, L. LAU, S. J. SCOTT, R. DAVIES, S. L. JOHNSTON, and P. H. HOWARTH The Relationship between Atopic Status and IL-10 Nasal Lavage Levels in the Acute and Persistent Inflammatory Response to Upper Respiratory Tract Infection Am. J. Respir. Crit. Care Med., April 1, 2001; 163(5): 1101 - 1107. [Abstract] [Full Text]

				S. Esposito, F. Blasi, F. Bellini, L. Allegra, and N. Principi Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia Eur. Respir. J., February 1, 2001; 17(2): 241 - 245. [Abstract] [Full Text] [PDF]

				M Roland, A Bhowmik, R J Sapsford, T A R Seemungal, D J Jeffries, T D Warner, and J A Wedzicha Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease Thorax, January 1, 2001; 56(1): 30 - 35. [Abstract] [Full Text]

				G. D Mills, J. A Lindeman, J P. Fawcett, G P. Herbison, and M. R Sears Chlamydia pneumoniae serological status is not associated with asthma in children or young adults Int. J. Epidemiol., April 1, 2000; 29(2): 280 - 284. [Abstract] [Full Text] [PDF]

				J. A. DOUGLASS and R. E. O'HEHIR What Determines Asthma Phenotype? . Respiratory Infections and Asthma Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): S211 - 214. [Full Text] [PDF]

				D. P. STRACHAN, D. CARRINGTON, M. MENDALL, B. K. BUTLAND, J. W. G. YARNELL, and P. ELWOOD Chlamydia pneumoniae Serology, Lung Function Decline, and Treatment for Respiratory Disease Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 493 - 497. [Abstract] [Full Text]

				J. Boman, C. A. Gaydos, and T. C. Quinn Molecular Diagnosis of Chlamydia pneumoniae Infection J. Clin. Microbiol., December 1, 1999; 37(12): 3791 - 3799. [Full Text]

				Y.-k. Wong, K. D. Dawkins, and M. E. Ward Circulating chlamydia pneumoniae DNA as a predictor of coronary artery disease J. Am. Coll. Cardiol., November 1, 1999; 34(5): 1435 - 1439. [Abstract] [Full Text] [PDF]

				P. J. Cook Antimicrobial therapy for Chlamydia pneumoniae: its potential role in atherosclerosis and asthma J. Antimicrob. Chemother., August 1, 1999; 44(2): 145 - 148. [Full Text] [PDF]

				M. Thomas, Y. Wong, D. Thomas, M. Ajaz, V. Tsang, P. J. Gallagher, and M. E. Ward Relation Between Direct Detection of Chlamydia pneumoniae DNA in Human Coronary Arteries at Postmortem Examination and Histological Severity (Stary Grading) of Associated Atherosclerotic Plaque Circulation, June 1, 1999; 99(21): 2733 - 2736. [Abstract] [Full Text] [PDF]